Explore every episode of the podcast Wisdom in Oncology
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Narrow in with a Laser Focus with Dr. Andrew Hendifar | 01 Apr 2025 | 00:07:54 | |
Andrew Hendifar, MD, is currently the Medical Director of Pancreatic Cancer at Samuel Oschin Comprehensive Cancer Center and an Assistant Professor of Medicine at Cedars-Sinai Medical Center. Dr. Hendifar received his medical degree from Tulane University and he did his residency in Internal Medicine at Los Angeles County, the USC Medical Center, followed by a fellowship in Hematology and Oncology from the University of Southern California. At Cedars Sinai he also leads the Gastrointestinal Disease Research Group and is the Program Director of the Hematology and Oncology Fellowship Program. His research focuses on developing new therapies for pancreatic cancer and neuroendocrine tumors. He is a member of the ASCO Society and North American Neuroendocrine Tumor Society. Pearls of Wisdom:
| |||
| Be Humble and Achieve High Intelligence with Dr. Erminia Massarelli | 24 Mar 2025 | 00:08:18 | |
Dr. Erminia Massarelli, MD is currently an Associate Professor of Medical Oncology and Therapeutics Research; Section Chief of Thoracic Oncology, and Co-Director of Lung Cancer and Thoracic Oncology Program at City of Hope Medical Center. Dr. Massarelli received her medical degree and Ph.D in Molecular Oncology and Endocrinology from the University of Naples in Federico, Italy. She continued her postdoctoral training with dual Medical Oncology and Thoracic Head & Neck Medical Oncology fellowships at MD Anderson Cancer Center, a residency in Internal Medicine at the Methodist Hospital in Houston, and a clinical fellowship in Medical Endocrinology at MD Anderson Cancer Center. Her clinical interests include lung cancer and head and neck cancers, and her research focuses on mechanisms of resistance to EGFR targeted therapy in non-small cell lung cancer, and cell therapy. Dr. Massarelli is the recipient of several honors and awards including the ASCO Conquer Cancer Foundation Young Investigator Award. She has published over 55 peer reviewed articles, numerous abstracts, and three book chapters. Pearls of Wisdom:
| |||
| Be Willing to Do Extra for a Patient with Dr. Yuan Yuan | 10 Mar 2025 | 00:11:02 | |
Dr. Yuan Yuan, MD is an Associate Professor of Medical Oncology and Pearls of Wisdom:
| |||
| Finding What You Love with Dr. James Allison | 03 Mar 2025 | 00:01:56 | |
Dr. James Allison, PhD is Regental Professor and Chair of the Department of Immunology, the Olga Keith Wiess Distinguished University Chair for Cancer Research, Director of the Parker Institute for Cancer Research, and the Executive Director of the Immunotherapy Platform at MD Anderson Cancer Center. He has spent a distinguished career studying the regulation of T cell responses and developing strategies for cancer immunotherapy. He earned the 2018 Nobel Prize in Physiology or Medicine, which he shared with Dr. Tasuku Honjo, "for their discovery of cancer therapy by inhibition of negative immune regulation." He studied at the University of Texas in Austin, and he received his PhD there in 1973. He worked at the Scripps Clinic and Research Foundation in La Jolla, California; University of Texas System Cancer Center, Smithville, Texas; University of California, Berkeley; Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medicine, New York; and Howard Hughes Medical Institute, Chevy Chase, Maryland. Since 2012 he has been a revered professor at the University of Texas MD Anderson Cancer Center in Houston. Pearls of Wisdom:
| |||
| Make Your Patient Win an Olympic Gold Medal with Dr. Swaminathan Iyer | 22 Aug 2022 | 00:23:39 | |
Swaminathan Iyer, MD, is currently the Professor of the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center and Professor of Medicine at the Houston Methodist Academic Institute and Weill Cornell Medicine. He completed his medical school from Bangalore Medical College, India and residency in Internal Medicine from Wayne State University, Michigan. He pursued a fellowship in Hematology/Oncology from Jackson Memorial Hospital, University of Miami, Florida. He is a nationally recognized leader in early drug development in hematologic malignancies. As the Section Chief of hematological malignancies and the Co-Director of the Cockrell Center for Advanced Therapeutics, he has an active role in the development of cutting-edge, targeted phase 1 therapies. He has been awarded Clinical Care Excellence Award from HealthNetwork and Virginia and Ernest Cockrell Presidential Award from Houston Methodist Research Institute and is a member of the American Society of Clinical Oncology, the American Association for Cancer Research, and the American Society of Hematology. Pearls of Wisdom:
| |||
| Be Considerate, Empathetic, and Compassionate with Dr. Steven Rosen | 17 Aug 2022 | 00:13:38 | |
Steven Rosen, MD, is the Provost and Chief Scientific Officer for the City of Hope. He is also the Director of the Comprehensive Cancer Center and the Beckman Research Institute and holds the Irell & Manella Cancer Center Director's Distinguished Chair and the Morgan & Helen Chu Director's Chair of the Beckman Research Institute. Following his graduation with distinction from Northwestern University's Medical School's six-year honors program in Chicago, Illinois, Dr. Rosen completed his residency in Internal Medicine at Northwestern and his fellowship in Hematology and Medical Oncology at the National Cancer Institute in Maryland. Prior to joining the City of Hope, Dr. Rosen was the Genevieve E. Teuton Professor of Medicine at Feinberg and Director of Cancer Programs at Northwestern Memorial Hospital. He served for 25 years as Director of Northwestern's Robert H. Lurie Comprehensive Cancer Center. Dr. Rosen has published more than 400 original reports, editorials, books, and book chapters. His research has been funded by the NCI, American Cancer Society, Leukemia and Lymphoma Society and Multiple Myeloma Research Foundation. Recognized as one of the best doctors in America, Dr. Rosen is a recipient of the Martin Luther King Humanitarian Award from Northwestern Memorial Hospital and the Man of Distinction Award from the Israel Cancer Research Fund. He is also a member of the Alpha Omega Alpha Honors Society. Pearls of Wisdom:
| |||
| Dr. Rowan Chlebowski on Delivering Impactful Products | 05 Jul 2022 | 00:11:39 | |
Today's guest is Dr. Rowan Chlebowski, one of the most influential breast cancer researchers in the world. Dr. Chlebowski is a clinical breast oncologist with a Ph.D. in reproductive biology, he has a credentialed clinical and research interest in breast cancer therapy and prevention, menopausal hormone therapy influences on cancer and chronic disease, and lifestyle influences on breast cancer incidence and outcome. He is best known for studying breast cancer issues in the Women's Health Initiative (WHI). He has published widely and led reports in well-cited journals such as JAMA, New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute, and JAMA Oncology. On this episode of Wisdom in Oncology, Dr. Chlebowski tells us how to become a high impact researcher. Dr. Chlebowski emphasizes the product, guiding us to the proper focus for achieving research excellence. Dr. Chlebowski also shares his advice for finding an appropriate mentor, choosing the right focus for research, and working with diligence. Talking points:
| |||
| Patient-Centric Care, Self-Care, and Teamwork: Masterful Advice from Dr. Heather Wakelee | 21 Jun 2022 | 00:11:21 | |
The guest of this episode is Heather Wakelee, M.D., a leading specialist in the treatment of lung cancer, thymoma and mesothelioma. Dr. Wakelee has been in practice for nearly two decades at Stanford University, and is currently a fellow of ASCO. She is the physician lead for the thoracic malignancies clinical research group and has developed research programs related to lung cancer and thymoma across multiple areas including clinical trials, translational work, and population sciences. Dr. Wakelee is the Principal Investigator on numerous clinical trials, and is the faculty director of the Stanford Cancer Clinical Trials office, as well as the Lead Investigator for ECOG-ACRIN clinical trials group at Stanford. It is a true privilege to receive Dr. Wakelee's insights. In this interview, Dr. Wakelee underscores patient-centric care that honors the humanity of the patient; discusses the importance of self-care; notes collaboration and teamwork as essential for true success; and offers encouragement for residents in building their research careers from the ground floor up. Thank you for tuning into this episode of Wisdom in Oncology with Dr. Wakelee. Enjoy! Talking points:
| |||
| Learning Persistence with Dr. Larissa Nekhlyudov | 07 Jun 2022 | 00:02:55 | |
Dr. Nekhlyudov is a Professor of Medicine at Harvard Medical School, the Clinical Director of Internal Medicine at David B. Perini Jr. Quality of Life Clinic, and an Internist at Longwood, and Brigham and Women's Hospital. Dr. Nekhlyudov is renowned for her extensive clinical and research expertise in cancer survivorship, and overall is a stalwart source of wisdom in medicine. We are grateful to have Dr. Nekhlyudov share her motivating messages on persistence, self-knowledge, and skillful discernment in receiving guidance from mentors and other colleagues. Though this segment is brief, Dr. Nekhlyudov packs a powerful and concise message that can benefit the listener. Thank you for joining us in receiving this inspiration from Dr. Nekhlyudov. Talking points:
| |||